Pulmonary exacerbations (PEs) reported for the two study groups
| PEP | HFCWO | p Value | |
|---|---|---|---|
| Number of PEs requiring antibiotics | 49 Median1.00 (0.00, 2.00) | 96 Median 2.00 (1.00, 3.00) | 0.007* |
| Number of PEs requiring intravenous antibiotics | 6 Median 0.00 (0.00, 0.00) | 19 Median 0.00 (0.00–1.00) | 0.258 |
| Median length in days of intravenous antibiotics per treatment | 14.5 (13, 17) | 14 (9.5, 15) | 0.484 |
| Number of PEs requiring oral/inhaled antibiotics | 43 Median 1.00 (0.00, 2.00) | 77 Median 2.00 (1.00, 3.00) | 0.025* |
*Significantly different at the p=0.05 level.
Data are presented as median (25%, 75% percentiles)
HFCWO, high frequency chest wall oscillation; PEP, positive expiratory pressure.